期刊文献+

乙型肝炎肝组织中Fas抗原检测 被引量:2

下载PDF
导出
摘要 目的探讨Fas抗原在慢性肝炎肝组织中表达、分布与肝组织损伤的关系。方法用抗-Fas多克隆抗体,以免疫组织化学技术对76例乙型肝炎肝组织中Fas抗原进行了检测。结果Fas抗原总检出率为69.74%。慢性迁延性肝炎(CPH)、慢性活动性肝炎(CAH)、活动性肝硬化(AC)的抗原检出率分别为43.48%、78.12%、85.71%。Fas抗原主要分布在肝细胞胞浆中,呈红色细颗粒状。Fas抗原阳性肝细胞分布在坏死灶边缘或假小叶周边。3组Fas抗原阳性率经统计学处理,CPH组与CAH及AC组有显著性差异(χ2=6.94及5.21),而CAH组与AC组无显著性差异(χ2=0.477)。
出处 《徐州医学院学报》 CAS 1998年第6期461-463,共3页 Acta Academiae Medicinae Xuzhou
  • 相关文献

参考文献4

  • 1任占平,郑绍光,陈尉麟.应用SP免疫组化染色法的体会[J].诊断病理学杂志,1994,1(3):176-176. 被引量:69
  • 2Itoh N, Yonehara, S, Ishii A, et al. The polypetide encoded by the DNA for human cell surface antigen Fas can modiate apoptosis. Cell, 1991,66(2):233.
  • 3Itoh N, Nagata S. A nevel protein domain required for apoptosis:Mutational analysis of human Fas antigen. J Biol Chem, 1993,268(15):10932.
  • 4Hiramatsu N, Hayachi N, Katayama K, et al. Immunohistochemical detection of Fas antigen in liver tissue of patient with chronic hepatitis C. Hepatology, 1994,19:1354.

二级参考文献1

  • 1施作榕.链霉菌亲生物素蛋白—生物素酶标免疫组化染色法的初步研究[J]中国免疫学杂志,1986(03).

共引文献68

同被引文献15

  • 1Nagata S, Golstein P. The Fas death factor. Science, 1995,27:1449
  • 2Mitsuo N, Nakajima Y, Hisanage M, et al. The alteration of Fas receptor and ligand system in hepatocellular carcinoma:how do hepatoma cells escape from the host immune surveillance in vivo? Hepatology,1999, 30(2) :413
  • 3Rimoldi D,Hahne M,Schroter M,et al. Melanoma cells express Fas(Apo- 1/CD 95 ) ligand: implications for tumor immune escape. Science, 1996,274: 4930
  • 4Hanabuchi S,kayanagi M, kawasaki A, et al. Fas and its ligand is a general mechanism of T-cell mediated cytoxicity. Proc Natl Acad Sci USA, 1994,91(11 ) :4930
  • 5Gratas C, Tohma Y, Barnas C, et al. Up-regulation of ( Apo - 1 /CD 95 ) ligand and down-regulation of Fas expression in human esophaageal cancer. Cancer Res, 1998,58(24): 5669
  • 6Natoli G, Ianni A,Costanzo A,et al. Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene, 1995,11 (6): 1157
  • 7Jodo S,kabayashi S,Nakajima Y,et al. Elevated serum levels of soluble Fas/Apo-1 (CD95)in patients with hepatocellular carcinoma. Clin Exp Immunol, 1998,112(2): 166
  • 8Faubion WA, Gores G. Death receptor in liver biology and pathobiology. Hepatology, 1999,29 ( 1 ) :461
  • 9俞顺章.肝癌流行病学与预防.汤钊猷主编:原发性肝癌.第2版.上海:上海科学技术出版社,1998:86~112
  • 10Griffith TS,Brunner T,Flecher SM. Fas ligand induced apoptosis as a mechanism of immune privilege. Science, 1995,270:1189

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部